252 related articles for article (PubMed ID: 12036002)
1. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.
French MT; Salomé HJ; Sindelar JL; McLellan AT
Health Serv Res; 2002 Apr; 37(2):433-55. PubMed ID: 12036002
[TBL] [Abstract][Full Text] [Related]
2. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
French MT; Salomé HJ; Carney M
Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
[TBL] [Abstract][Full Text] [Related]
3. Estimating the economic cost of substance abuse treatment.
French MT; McGeary KA
Health Econ; 1997; 6(5):539-44. PubMed ID: 9353658
[TBL] [Abstract][Full Text] [Related]
4. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).
Salomé HJ; French MT; Miller M; McLellan AT
Drug Alcohol Depend; 2003 Aug; 71(2):195-206. PubMed ID: 12927658
[TBL] [Abstract][Full Text] [Related]
5. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP).
French MT; Dunlap LJ; Zarkin GA; McGeary KA; McLellan AT
J Subst Abuse Treat; 1997; 14(5):445-55. PubMed ID: 9437614
[TBL] [Abstract][Full Text] [Related]
6. Cost estimation when time and resources are limited: the Brief DATCAP.
French MT; Roebuck MC; McLellan AT
J Subst Abuse Treat; 2004 Oct; 27(3):187-93. PubMed ID: 15501371
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes.
Sindelar JL; Jofre-Bonet M; French MT; McLellan AT
Drug Alcohol Depend; 2004 Jan; 73(1):41-50. PubMed ID: 14687958
[TBL] [Abstract][Full Text] [Related]
8. Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington.
French MT; Salomé HJ; Krupski A; McKay JR; Donovan DM; McLellan AT; Durell J
Eval Rev; 2000 Dec; 24(6):609-34. PubMed ID: 11151519
[TBL] [Abstract][Full Text] [Related]
9. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
[TBL] [Abstract][Full Text] [Related]
10. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
Mojtabai R; Zivin JG
Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
[TBL] [Abstract][Full Text] [Related]
12. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
[TBL] [Abstract][Full Text] [Related]
13. Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations.
Reckers-Droog V; Goorden M; Kaminer Y; van Domburgh L; Brouwer W; Hakkaart-van Roijen L
PLoS One; 2020; 15(9):e0238858. PubMed ID: 32915870
[TBL] [Abstract][Full Text] [Related]
14. Service-level costing of drug abuse treatment.
Anderson DW; Bowland BJ; Cartwright WS; Bassin G
J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
[TBL] [Abstract][Full Text] [Related]
15. Using cost and financing instruments for economic evaluation of substance abuse treatment services.
Salomé HJ; French MT
Recent Dev Alcohol; 2001; 15():253-69. PubMed ID: 11449745
[TBL] [Abstract][Full Text] [Related]
16. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
Woodward AM; Raskin IE; Blacklow B
Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
[TBL] [Abstract][Full Text] [Related]
17. DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program.
Roebuck MC; French MT; McLellan AT
J Subst Abuse Treat; 2003 Jul; 25(1):51-7. PubMed ID: 14512108
[TBL] [Abstract][Full Text] [Related]
18. The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment.
French MT; Roebuck MC; Dennis ML; Diamond G; Godley SH; Tims F; Webb C; Herrell JM
Addiction; 2002 Dec; 97 Suppl 1():84-97. PubMed ID: 12460131
[TBL] [Abstract][Full Text] [Related]
19. Benefit-cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women.
French MT; McCollister KE; Cacciola J; Durell J; Stephens RL
Subst Abus; 2002 Mar; 23(1):31-51. PubMed ID: 12444359
[TBL] [Abstract][Full Text] [Related]
20. Integrating primary medical care with addiction treatment: a randomized controlled trial.
Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
